Subcutaneous Drug Delivery Devices Market Trends Report 2025 – For Business Development and Strategy Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Subcutaneous Drug Delivery Devices Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for subcutaneous drug delivery devices has seen substantial growth in the past few years. It is projected to increase from $27.66 billion in 2024 to $29.77 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this growth in the historical period include the heightened occurrence of chronic diseases, the growing need for self-administration of medication, increasing rates of diabetes and obesity, patient preference towards convenient therapeutic methods, and a surge in the ageing population.
What Is the Forecast for the Subcutaneous Drug Delivery Devices Market Size Through 2029?
In the upcoming years, the market size of subcutaneous drug delivery devices is projected to experience substantial growth, reaching approximately $39.57 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%. This prosperous forecasted period is due to several factors, such as the expansion of the biologics and biosimilars market, the increasing acceptance of wearable drug delivery systems, the growth of personalized medicine, enhancements in healthcare reimbursement policies, and a heightened focus on home healthcare. The forecast period will also see a set of notable trends, including the amalgamation of digital health technology, the production of intelligent and connected devices, the popularity of minimally invasive procedures, advancements in needle-less injection systems, and the rise of artificial intelligence in the development of devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
What are the Key Market Players in Subcutaneous Drug Delivery Devices Market and How They’re Evolving?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
What Are the Primary Growth Drivers in the Subcutaneous Drug Delivery Devices Market?
The uptick in instances of diabetes and cardiovascular diseases (CVD) is anticipated to stimulate the expansion of the subcutaneous drug delivery devices market. This escalation in diabetes and cardiovascular illnesses can be attributed to factors such as growing elderly populations, unhealthy eating habits, lack of physical activity, obesity, economic disparities, stress, environmental influences, and scarce preventive healthcare resources. Subcutaneous drug delivery devices, used to provide insulin and other medications for maintaining blood sugar levels in diabetes patients, and drugs like anticoagulants or lipid-lowering agents for cardiovascular disease management, present a practical and regulated approach to handle these ongoing ailments. As an example, the British Diabetic Association, a UK-based charity for individuals dealing with diabetes, disclosed new data in April 2023 stating that 4.3 million people in the UK have been diagnosed with diabetes. The number of recorded cases in 2021-22 witnessed an elevation of 148,951 when juxtaposed with 2020-21 data, revealing that over 2.4 million people face a substantial risk of developing type 2 diabetes in the UK. Also, the Centers for Disease Control and Prevention, a US-based federal agency, declared in May 2024, that heart disease was responsible for the deaths of 702,880 individuals in 2022, representing one in every five mortalities. Hence, the surging prevalence of diabetes and cardiovascular diseases (CVD) is fuelling growth in the subcutaneous drug delivery devices market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19723&type=smp
What Are the Leading Segments in the Global Subcutaneous Drug Delivery Devices Industry?
The subcutaneous drug delivery devicesmarket covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) Pen Needles: Standard Pen Needles, Safety Pen Needles
3) Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
What Are the Key Market Trends in the Subcutaneous Drug Delivery Devices Industry?
Leading businesses in the subcutaneous drug delivery devices market are concentrating on producing pioneering products like miniature digital liquid flow sensors. These products are aimed at improving subcutaneous drug delivery’s safety and precision by offering precise, customizable flow sensors for large-volume injectors. Miniature digital liquid flow sensors are tiny, accurate devices used to gauge liquid flow rates in small-scale applications, giving digital reporting for precise monitoring and control. For example, Sensirion AG, a Swiss firm specializing in environmental and flow sensors, released the SLD3x series sensor platform in May 2024. This series boasts highly precise digital liquid flow sensors with the option for customized solutions, ensuring precise flow measurement, occlusion discovery, in-line air bubble detection, and liquid temperature tracking. These tiny sensors are perfect for large-scale medical device production, promising optimal dosage and improved patient safety in subcutaneous drug delivery.
Access The Full Report Here:
What Is the Regional Outlook for the Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19723
This Report Delivers Insight On:
1. How big is the subcutaneous drug delivery devices market, and how is it changing globally?
2. Who are the major companies in the subcutaneous drug delivery devices market, and how are they performing?
3. What are the key opportunities and risks in the subcutaneous drug delivery devices market right now?
4. Which products or customer segments are growing the most in the subcutaneous drug delivery devices market?
5. What factors are helping or slowing down the growth of the subcutaneous drug delivery devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
